Approval · Notice of Compliance 24764 · 2020
AMBISOME: Notice of Compliance 24764
Issued December 9, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24764
- Date
- December 9, 2020
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternative drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMBISOME | Not yet assigned | — |
Medicinal ingredients
- AMPHOTERICIN B 50 MG per VIAL